

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 6.96983251 |
| 2 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 6.44019053 |
| 3 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 6.39684967 |
| 4 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.34822288 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.24173202 |
| 6 | cardiac myofibril assembly (GO:0055003) | 6.13310226 |
| 7 | endocardial cushion development (GO:0003197) | 6.05927914 |
| 8 | sarcomere organization (GO:0045214) | 6.01524518 |
| 9 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.79873535 |
| 10 | regulation of relaxation of muscle (GO:1901077) | 5.59084374 |
| 11 | tricarboxylic acid cycle (GO:0006099) | 5.48317633 |
| 12 | cardiac muscle contraction (GO:0060048) | 5.26631399 |
| 13 | cell migration involved in heart development (GO:0060973) | 5.25917828 |
| 14 | regulation of cell communication by electrical coupling (GO:0010649) | 5.23615220 |
| 15 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.16799870 |
| 16 | myofibril assembly (GO:0030239) | 5.16473838 |
| 17 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 5.10196595 |
| 18 | regulation of actin filament-based movement (GO:1903115) | 5.00656907 |
| 19 | bone trabecula formation (GO:0060346) | 4.92116643 |
| 20 | regulation of cardioblast differentiation (GO:0051890) | 4.90736318 |
| 21 | cell communication involved in cardiac conduction (GO:0086065) | 4.86514744 |
| 22 | cardiac chamber formation (GO:0003207) | 4.74864981 |
| 23 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.70458176 |
| 24 | pericardium development (GO:0060039) | 4.68645047 |
| 25 | atrial septum morphogenesis (GO:0060413) | 4.64281961 |
| 26 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.60873846 |
| 27 | regulation of membrane repolarization (GO:0060306) | 4.58546115 |
| 28 | sequestering of extracellular ligand from receptor (GO:0035581) | 4.53718907 |
| 29 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 4.52750065 |
| 30 | cell communication by electrical coupling (GO:0010644) | 4.45767889 |
| 31 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 4.37149488 |
| 32 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.35260483 |
| 33 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 4.33895296 |
| 34 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 4.31714427 |
| 35 | plasma membrane repair (GO:0001778) | 4.31247372 |
| 36 | outflow tract septum morphogenesis (GO:0003148) | 4.30898297 |
| 37 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 4.24330619 |
| 38 | cardiac muscle cell development (GO:0055013) | 4.20505094 |
| 39 | regulation of sarcomere organization (GO:0060297) | 4.20371860 |
| 40 | regulation of cardiac muscle cell contraction (GO:0086004) | 4.18255415 |
| 41 | regulation of striated muscle contraction (GO:0006942) | 4.16175863 |
| 42 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 4.15803210 |
| 43 | cardiac muscle hypertrophy (GO:0003300) | 4.14318467 |
| 44 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.12956375 |
| 45 | detection of calcium ion (GO:0005513) | 4.08398642 |
| 46 | regulation of cardiac muscle contraction (GO:0055117) | 4.06904926 |
| 47 | protein heterotrimerization (GO:0070208) | 4.02012460 |
| 48 | regulation of the force of heart contraction (GO:0002026) | 4.01040269 |
| 49 | relaxation of cardiac muscle (GO:0055119) | 4.00089239 |
| 50 | respiratory electron transport chain (GO:0022904) | 3.99685802 |
| 51 | atrioventricular valve morphogenesis (GO:0003181) | 3.98229251 |
| 52 | regulation of cofactor metabolic process (GO:0051193) | 3.97004009 |
| 53 | regulation of coenzyme metabolic process (GO:0051196) | 3.97004009 |
| 54 | ATP synthesis coupled proton transport (GO:0015986) | 3.96055360 |
| 55 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 3.96055360 |
| 56 | electron transport chain (GO:0022900) | 3.94730915 |
| 57 | extracellular matrix assembly (GO:0085029) | 3.94553182 |
| 58 | striated muscle hypertrophy (GO:0014897) | 3.93487374 |
| 59 | adult heart development (GO:0007512) | 3.91492545 |
| 60 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 3.90965202 |
| 61 | cardiac cell development (GO:0055006) | 3.90108341 |
| 62 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.87136202 |
| 63 | positive regulation of cardiac muscle tissue development (GO:0055025) | 3.85638691 |
| 64 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.82190995 |
| 65 | cardiac ventricle formation (GO:0003211) | 3.81512176 |
| 66 | cardiac conduction (GO:0061337) | 3.79537404 |
| 67 | type B pancreatic cell proliferation (GO:0044342) | 3.77899151 |
| 68 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.77725283 |
| 69 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.77571061 |
| 70 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.77571061 |
| 71 | striated muscle contraction (GO:0006941) | 3.77222147 |
| 72 | endocardial cushion morphogenesis (GO:0003203) | 3.75640118 |
| 73 | venous blood vessel morphogenesis (GO:0048845) | 3.75517716 |
| 74 | actomyosin structure organization (GO:0031032) | 3.75306533 |
| 75 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.72062561 |
| 76 | collagen fibril organization (GO:0030199) | 3.69891000 |
| 77 | positive regulation of cardiac muscle cell proliferation (GO:0060045) | 3.67588666 |
| 78 | carnitine shuttle (GO:0006853) | 3.67088192 |
| 79 | heart trabecula formation (GO:0060347) | 3.64810813 |
| 80 | muscle filament sliding (GO:0030049) | 3.63815052 |
| 81 | actin-myosin filament sliding (GO:0033275) | 3.63815052 |
| 82 | cardiac muscle cell action potential (GO:0086001) | 3.62377731 |
| 83 | regulation of heart rate by cardiac conduction (GO:0086091) | 3.62315894 |
| 84 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.62239568 |
| 85 | negative regulation of potassium ion transport (GO:0043267) | 3.59001157 |
| 86 | regulation of transcription from RNA polymerase II promoter involved in heart development (GO:190121 | 3.57963970 |
| 87 | regulation of heart rate (GO:0002027) | 3.57776481 |
| 88 | positive regulation of cation channel activity (GO:2001259) | 3.57770133 |
| 89 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.57461987 |
| 90 | kidney mesenchyme development (GO:0072074) | 3.54913578 |
| 91 | positive regulation of cardiac muscle tissue growth (GO:0055023) | 3.53761665 |
| 92 | oxygen transport (GO:0015671) | 3.52865441 |
| 93 | NADH metabolic process (GO:0006734) | 3.51160046 |
| 94 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.46885694 |
| 95 | negative regulation of striated muscle cell apoptotic process (GO:0010664) | 3.43658044 |
| 96 | muscle hypertrophy (GO:0014896) | 3.41527736 |
| 97 | negative regulation of cardiac muscle cell apoptotic process (GO:0010667) | 3.38973314 |
| 98 | mesenchyme morphogenesis (GO:0072132) | 3.38882458 |
| 99 | regulation of skeletal muscle contraction (GO:0014819) | 3.37885896 |
| 100 | muscle tissue morphogenesis (GO:0060415) | 3.36652742 |
| 101 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 3.36370375 |
| 102 | skin morphogenesis (GO:0043589) | 3.31147221 |
| 103 | neurological system process involved in regulation of systemic arterial blood pressure (GO:0001976) | 3.29859557 |
| 104 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.28763391 |
| 105 | trabecula formation (GO:0060343) | 3.26874562 |
| 106 | endodermal cell differentiation (GO:0035987) | 3.26632321 |
| 107 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.25886822 |
| 108 | regulation of cardiac muscle cell differentiation (GO:2000725) | 3.25843383 |
| 109 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.22081187 |
| 110 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.22081187 |
| 111 | positive regulation of heart rate (GO:0010460) | 3.21816636 |
| 112 | fatty acid transmembrane transport (GO:1902001) | 3.21414362 |
| 113 | relaxation of muscle (GO:0090075) | 3.21150154 |
| 114 | adhesion of symbiont to host cell (GO:0044650) | 3.20297600 |
| 115 | virion attachment to host cell (GO:0019062) | 3.20297600 |
| 116 | heart contraction (GO:0060047) | 3.20261745 |
| 117 | heart process (GO:0003015) | 3.20261745 |
| 118 | * regulation of heart contraction (GO:0008016) | 3.19940172 |
| 119 | regulation of cardiac muscle tissue development (GO:0055024) | 3.17604499 |
| 120 | regulation of sulfur metabolic process (GO:0042762) | 3.17367445 |
| 121 | positive regulation of heart growth (GO:0060421) | 3.16065436 |
| 122 | actin-mediated cell contraction (GO:0070252) | 3.14641310 |
| 123 | succinate metabolic process (GO:0006105) | 3.13251529 |
| 124 | adrenergic receptor signaling pathway (GO:0071875) | 3.13158621 |
| 125 | relaxation of smooth muscle (GO:0044557) | 3.12643300 |
| 126 | regulation of cation channel activity (GO:2001257) | 3.10774092 |
| 127 | regulation of glucocorticoid metabolic process (GO:0031943) | 3.08951711 |
| 128 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 3.08276817 |
| 129 | positive regulation of potassium ion transport (GO:0043268) | 3.07140880 |
| 130 | chondrocyte proliferation (GO:0035988) | 3.07034527 |
| 131 | cardiac muscle tissue development (GO:0048738) | 3.06107312 |
| 132 | phenol-containing compound catabolic process (GO:0019336) | 3.06002810 |
| 133 | regulation of cardioblast proliferation (GO:0003264) | 3.04646102 |
| 134 | regulation of secondary heart field cardioblast proliferation (GO:0003266) | 3.04646102 |
| 135 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.04493814 |
| 136 | regulation of potassium ion transmembrane transport (GO:1901379) | 3.03402598 |
| 137 | ventricular cardiac muscle cell development (GO:0055015) | 3.03050889 |
| 138 | respiratory tube development (GO:0030323) | 3.01562647 |
| 139 | cellular response to epinephrine stimulus (GO:0071872) | 3.00919106 |
| 140 | oxidative phosphorylation (GO:0006119) | 2.99802989 |
| 141 | positive regulation of heart contraction (GO:0045823) | 2.98822306 |
| 142 | cardiac septum development (GO:0003279) | 2.95820124 |
| 143 | regulation of cardiac muscle cell proliferation (GO:0060043) | 2.95429781 |
| 144 | response to epinephrine (GO:0071871) | 2.92994076 |
| 145 | cardiac muscle adaptation (GO:0014887) | 2.91577431 |
| 146 | muscle hypertrophy in response to stress (GO:0003299) | 2.91577431 |
| 147 | negative regulation of hormone metabolic process (GO:0032351) | 2.89762035 |
| 148 | cellular response to vitamin (GO:0071295) | 2.89273767 |
| 149 | metanephric mesenchyme development (GO:0072075) | 2.87849569 |
| 150 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.87533748 |
| 151 | lung vasculature development (GO:0060426) | 2.82135226 |
| 152 | actin filament-based movement (GO:0030048) | 2.81231002 |
| 153 | regulation of cardiac muscle cell apoptotic process (GO:0010665) | 2.79858346 |
| 154 | mesodermal cell differentiation (GO:0048333) | 2.79511823 |
| 155 | response to redox state (GO:0051775) | 2.76247641 |
| 156 | regulation of muscle contraction (GO:0006937) | 2.75762729 |
| 157 | positive regulation of cardiac muscle hypertrophy (GO:0010613) | 2.73929653 |
| 158 | positive regulation of muscle hypertrophy (GO:0014742) | 2.73929653 |
| 159 | embryonic foregut morphogenesis (GO:0048617) | 2.70612675 |
| 160 | regulation of smooth muscle cell differentiation (GO:0051150) | 2.68706043 |
| 161 | positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511) | 2.66728519 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.10170406 |
| 2 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 4.24517698 |
| 3 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.97173424 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.38673884 |
| 5 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.22713575 |
| 6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.81501276 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.73854028 |
| 8 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.66276003 |
| 9 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58868853 |
| 10 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.38147254 |
| 11 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27633839 |
| 12 | BRD4_25478319_ChIP-Seq_HGPS_Human | 2.23781178 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.22208420 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.22208420 |
| 15 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.21804463 |
| 16 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.12420923 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.10634549 |
| 18 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 2.08803066 |
| 19 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.02933982 |
| 20 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.01309022 |
| 21 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98980269 |
| 22 | * NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.97757765 |
| 23 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.97393127 |
| 24 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.97269534 |
| 25 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.97269534 |
| 26 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.97199158 |
| 27 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.97175013 |
| 28 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.97007523 |
| 29 | CJUN_26792858_Chip-Seq_BT549_Human | 1.95222472 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.92261808 |
| 31 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.90773376 |
| 32 | TP53_16413492_ChIP-PET_HCT116_Human | 1.89076192 |
| 33 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.87143460 |
| 34 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.82939128 |
| 35 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.76323849 |
| 36 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.75919655 |
| 37 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.74905872 |
| 38 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.71694498 |
| 39 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.70335253 |
| 40 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.67436432 |
| 41 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.64239267 |
| 42 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.64020718 |
| 43 | * REST_21632747_ChIP-Seq_MESCs_Mouse | 1.62533006 |
| 44 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.58372529 |
| 45 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.57571252 |
| 46 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.57247586 |
| 47 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.56522097 |
| 48 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.55354422 |
| 49 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.51402087 |
| 50 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.49488023 |
| 51 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.45361453 |
| 52 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.45233722 |
| 53 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.44791257 |
| 54 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.43347508 |
| 55 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.41120521 |
| 56 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.40885431 |
| 57 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.40639641 |
| 58 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.37861302 |
| 59 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.37297262 |
| 60 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.35568439 |
| 61 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.34584996 |
| 62 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30957143 |
| 63 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30006256 |
| 64 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.29480907 |
| 65 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.28049052 |
| 66 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.27820684 |
| 67 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.24764314 |
| 68 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.23398263 |
| 69 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.21704887 |
| 70 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.19729211 |
| 71 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.19170142 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.18106345 |
| 73 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.17687798 |
| 74 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.16844621 |
| 75 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.16096808 |
| 76 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.11307779 |
| 77 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.11089595 |
| 78 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10221829 |
| 79 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.10117386 |
| 80 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.10099247 |
| 81 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.09618037 |
| 82 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08864679 |
| 83 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.07921458 |
| 84 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.07744388 |
| 85 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.07723702 |
| 86 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.07578898 |
| 87 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.07316147 |
| 88 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.06687144 |
| 89 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.05648626 |
| 90 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.05210081 |
| 91 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.04241561 |
| 92 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04168838 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.03897523 |
| 94 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.03248631 |
| 95 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.01537951 |
| 96 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.01216727 |
| 97 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.00920397 |
| 98 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.00848397 |
| 99 | AR_25329375_ChIP-Seq_VCAP_Human | 1.00367169 |
| 100 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.00101638 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.99085262 |
| 102 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.98767948 |
| 103 | AR_19668381_ChIP-Seq_PC3_Human | 0.98472016 |
| 104 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.98346053 |
| 105 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.98290981 |
| 106 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 0.97284524 |
| 107 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.97279845 |
| 108 | VDR_22108803_ChIP-Seq_LS180_Human | 0.96539504 |
| 109 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.96307927 |
| 110 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.95920994 |
| 111 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.95367988 |
| 112 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.95357865 |
| 113 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.95267890 |
| 114 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.95145097 |
| 115 | * PPARD_21283829_ChIP-Seq_MYOFIBROBLAST_Human | 0.94406501 |
| 116 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.94093580 |
| 117 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.94074285 |
| 118 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 0.93383901 |
| 119 | TCF4_23295773_ChIP-Seq_U87_Human | 0.92915210 |
| 120 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.92628342 |
| 121 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.92222894 |
| 122 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 0.91887431 |
| 123 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 0.90337216 |
| 124 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.90189048 |
| 125 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.90023369 |
| 126 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.89933664 |
| 127 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.89568453 |
| 128 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.89484547 |
| 129 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.88248744 |
| 130 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 0.87513701 |
| 131 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.87496423 |
| 132 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.87487910 |
| 133 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.86809159 |
| 134 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.86651001 |
| 135 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.86651001 |
| 136 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.86171108 |
| 137 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.86023969 |
| 138 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.85644616 |
| 139 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 0.85623001 |
| 140 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 0.85617117 |
| 141 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.83880501 |
| 142 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.81429042 |
| 143 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81420005 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 5.96025963 |
| 2 | MP0008438_abnormal_cutaneous_collagen | 5.66616422 |
| 3 | MP0004084_abnormal_cardiac_muscle | 4.95603465 |
| 4 | MP0003646_muscle_fatigue | 4.87758555 |
| 5 | MP0000751_myopathy | 4.52725218 |
| 6 | MP0004215_abnormal_myocardial_fiber | 4.46626152 |
| 7 | MP0005503_abnormal_tendon_morphology | 3.98448638 |
| 8 | MP0004036_abnormal_muscle_relaxation | 3.66441096 |
| 9 | MP0002822_catalepsy | 3.37152082 |
| 10 | MP0005330_cardiomyopathy | 3.17087665 |
| 11 | MP0004272_abnormal_basement_membrane | 3.16215665 |
| 12 | MP0001958_emphysema | 3.07517036 |
| 13 | MP0003705_abnormal_hypodermis_morpholog | 3.05944872 |
| 14 | MP0005275_abnormal_skin_tensile | 3.01939332 |
| 15 | MP0000749_muscle_degeneration | 2.81725499 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.75465036 |
| 17 | MP0002972_abnormal_cardiac_muscle | 2.73232429 |
| 18 | MP0009384_cardiac_valve_regurgitation | 2.67655278 |
| 19 | MP0004484_altered_response_of | 2.62041550 |
| 20 | MP0003137_abnormal_impulse_conducting | 2.61673684 |
| 21 | MP0005257_abnormal_intraocular_pressure | 2.38085746 |
| 22 | MP0004087_abnormal_muscle_fiber | 2.34381475 |
| 23 | MP0004130_abnormal_muscle_cell | 2.29809588 |
| 24 | MP0006138_congestive_heart_failure | 2.24204658 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.23854513 |
| 26 | MP0005385_cardiovascular_system_phenoty | 2.23854513 |
| 27 | * MP0005620_abnormal_muscle_contractility | 2.21566980 |
| 28 | * MP0004085_abnormal_heartbeat | 2.16892101 |
| 29 | MP0003566_abnormal_cell_adhesion | 2.04597419 |
| 30 | MP0001542_abnormal_bone_strength | 2.03037165 |
| 31 | MP0000767_abnormal_smooth_muscle | 2.00349010 |
| 32 | MP0003941_abnormal_skin_development | 1.98697728 |
| 33 | MP0010630_abnormal_cardiac_muscle | 1.95259056 |
| 34 | MP0002106_abnormal_muscle_physiology | 1.93570397 |
| 35 | MP0004859_abnormal_synaptic_plasticity | 1.88559048 |
| 36 | MP0004145_abnormal_muscle_electrophysio | 1.86708867 |
| 37 | MP0000750_abnormal_muscle_regeneration | 1.82849935 |
| 38 | MP0004510_myositis | 1.80406195 |
| 39 | MP0006054_spinal_hemorrhage | 1.77079615 |
| 40 | MP0002295_abnormal_pulmonary_circulatio | 1.69681737 |
| 41 | MP0002127_abnormal_cardiovascular_syste | 1.69650556 |
| 42 | MP0000747_muscle_weakness | 1.68725520 |
| 43 | MP0000534_abnormal_ureter_morphology | 1.68547235 |
| 44 | MP0003828_pulmonary_edema | 1.66619142 |
| 45 | MP0002269_muscular_atrophy | 1.66026607 |
| 46 | MP0005369_muscle_phenotype | 1.60916446 |
| 47 | MP0005508_abnormal_skeleton_morphology | 1.59185335 |
| 48 | MP0003880_abnormal_central_pattern | 1.59081690 |
| 49 | * MP0003635_abnormal_synaptic_transmissio | 1.54403152 |
| 50 | MP0003221_abnormal_cardiomyocyte_apopto | 1.53289326 |
| 51 | MP0002332_abnormal_exercise_endurance | 1.53221448 |
| 52 | MP0003091_abnormal_cell_migration | 1.53029976 |
| 53 | MP0004233_abnormal_muscle_weight | 1.52734137 |
| 54 | MP0000759_abnormal_skeletal_muscle | 1.52041990 |
| 55 | MP0004270_analgesia | 1.49409174 |
| 56 | MP0001299_abnormal_eye_distance/ | 1.48660359 |
| 57 | MP0006036_abnormal_mitochondrial_physio | 1.45962514 |
| 58 | MP0003942_abnormal_urinary_system | 1.43524219 |
| 59 | * MP0009745_abnormal_behavioral_response | 1.41690862 |
| 60 | MP0009250_abnormal_appendicular_skeleto | 1.39732503 |
| 61 | MP0002909_abnormal_adrenal_gland | 1.38337175 |
| 62 | MP0006276_abnormal_autonomic_nervous | 1.37079543 |
| 63 | MP0009046_muscle_twitch | 1.36162849 |
| 64 | MP0002064_seizures | 1.35406070 |
| 65 | MP0001440_abnormal_grooming_behavior | 1.32764083 |
| 66 | MP0002102_abnormal_ear_morphology | 1.31882911 |
| 67 | MP0004858_abnormal_nervous_system | 1.30577507 |
| 68 | MP0005595_abnormal_vascular_smooth | 1.23428711 |
| 69 | * MP0004924_abnormal_behavior | 1.22424480 |
| 70 | * MP0005386_behavior/neurological_phenoty | 1.22424480 |
| 71 | MP0002735_abnormal_chemical_nociception | 1.19094185 |
| 72 | MP0000462_abnormal_digestive_system | 1.19064533 |
| 73 | MP0002254_reproductive_system_inflammat | 1.16894774 |
| 74 | MP0002734_abnormal_mechanical_nocicepti | 1.14901114 |
| 75 | MP0002128_abnormal_blood_circulation | 1.14693007 |
| 76 | * MP0002272_abnormal_nervous_system | 1.14481922 |
| 77 | MP0003385_abnormal_body_wall | 1.14261728 |
| 78 | MP0006035_abnormal_mitochondrial_morpho | 1.12154799 |
| 79 | MP0000733_abnormal_muscle_development | 1.12113006 |
| 80 | MP0002063_abnormal_learning/memory/cond | 1.10860351 |
| 81 | MP0009780_abnormal_chondrocyte_physiolo | 1.09680761 |
| 82 | MP0002572_abnormal_emotion/affect_behav | 1.05648291 |
| 83 | MP0010386_abnormal_urinary_bladder | 1.04947257 |
| 84 | MP0005165_increased_susceptibility_to | 1.01773951 |
| 85 | MP0002896_abnormal_bone_mineralization | 1.01264704 |
| 86 | MP0008004_abnormal_stomach_pH | 1.00637677 |
| 87 | MP0005023_abnormal_wound_healing | 0.98854007 |
| 88 | MP0005623_abnormal_meninges_morphology | 0.98419874 |
| 89 | MP0000428_abnormal_craniofacial_morphol | 0.98021644 |
| 90 | MP0008569_lethality_at_weaning | 0.97969507 |
| 91 | * MP0001970_abnormal_pain_threshold | 0.97331100 |
| 92 | MP0004043_abnormal_pH_regulation | 0.97241417 |
| 93 | MP0002638_abnormal_pupillary_reflex | 0.95437779 |
| 94 | MP0002733_abnormal_thermal_nociception | 0.94964376 |
| 95 | MP0001501_abnormal_sleep_pattern | 0.93289934 |
| 96 | MP0001905_abnormal_dopamine_level | 0.92686074 |
| 97 | MP0000013_abnormal_adipose_tissue | 0.91860150 |
| 98 | MP0001968_abnormal_touch/_nociception | 0.90686673 |
| 99 | MP0000230_abnormal_systemic_arterial | 0.90681371 |
| 100 | MP0003950_abnormal_plasma_membrane | 0.90385161 |
| 101 | MP0001879_abnormal_lymphatic_vessel | 0.89794210 |
| 102 | MP0001348_abnormal_lacrimal_gland | 0.89243077 |
| 103 | MP0003567_abnormal_fetal_cardiomyocyte | 0.89120350 |
| 104 | MP0002067_abnormal_sensory_capabilities | 0.88842977 |
| 105 | MP0003279_aneurysm | 0.87122334 |
| 106 | MP0003633_abnormal_nervous_system | 0.85845310 |
| 107 | MP0009053_abnormal_anal_canal | 0.85630502 |
| 108 | MP0005535_abnormal_body_temperature | 0.85510226 |
| 109 | MP0003283_abnormal_digestive_organ | 0.83433045 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.81699336 |
| 111 | MP0000266_abnormal_heart_morphology | 0.81134468 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.79417133 |
| 113 | MP0001486_abnormal_startle_reflex | 0.76861037 |
| 114 | MP0001243_abnormal_dermal_layer | 0.75255475 |
| 115 | MP0005390_skeleton_phenotype | 0.75162911 |
| 116 | MP0010368_abnormal_lymphatic_system | 0.74839234 |
| 117 | MP0001614_abnormal_blood_vessel | 0.74093805 |
| 118 | MP0003329_amyloid_beta_deposits | 0.73618703 |
| 119 | MP0000343_altered_response_to | 0.73277207 |
| 120 | MP0005167_abnormal_blood-brain_barrier | 0.72351331 |
| 121 | MP0005666_abnormal_adipose_tissue | 0.72220674 |
| 122 | MP0002108_abnormal_muscle_morphology | 0.71858824 |
| 123 | MP0004142_abnormal_muscle_tone | 0.71583164 |
| 124 | MP0003935_abnormal_craniofacial_develop | 0.71213987 |
| 125 | MP0002925_abnormal_cardiovascular_devel | 0.68071930 |
| 126 | MP0002060_abnormal_skin_morphology | 0.67792099 |
| 127 | MP0010352_gastrointestinal_tract_polyps | 0.67385228 |
| 128 | MP0002115_abnormal_skeleton_extremities | 0.66617128 |
| 129 | MP0002234_abnormal_pharynx_morphology | 0.66318486 |
| 130 | MP0010030_abnormal_orbit_morphology | 0.65997025 |
| 131 | MP0003937_abnormal_limbs/digits/tail_de | 0.65782422 |
| 132 | MP0001661_extended_life_span | 0.65755853 |
| 133 | MP0002184_abnormal_innervation | 0.65067175 |
| 134 | MP0005266_abnormal_metabolism | 0.63808419 |
| 135 | MP0005423_abnormal_somatic_nervous | 0.62715238 |
| 136 | MP0004147_increased_porphyrin_level | 0.62583366 |
| 137 | MP0002736_abnormal_nociception_after | 0.62373857 |
| 138 | MP0000049_abnormal_middle_ear | 0.61987305 |
| 139 | MP0002066_abnormal_motor_capabilities/c | 0.61340313 |
| 140 | MP0000432_abnormal_head_morphology | 0.60632156 |
| 141 | MP0000163_abnormal_cartilage_morphology | 0.60073209 |
| 142 | MP0003045_fibrosis | 0.59665487 |
| 143 | MP0003631_nervous_system_phenotype | 0.58468106 |
| 144 | MP0005187_abnormal_penis_morphology | 0.58028053 |
| 145 | MP0003122_maternal_imprinting | 0.57188083 |
| 146 | MP0004134_abnormal_chest_morphology | 0.57101684 |
| 147 | MP0004811_abnormal_neuron_physiology | 0.56999918 |
| 148 | MP0005171_absent_coat_pigmentation | 0.56657966 |
| 149 | MP0001664_abnormal_digestion | 0.56289130 |
| 150 | MP0005164_abnormal_response_to | 0.55448390 |
| 151 | MP0002090_abnormal_vision | 0.54389170 |
| 152 | MP0008872_abnormal_physiological_respon | 0.53986253 |
| 153 | MP0003755_abnormal_palate_morphology | 0.52943896 |
| 154 | MP0005375_adipose_tissue_phenotype | 0.52287278 |
| 155 | MP0002078_abnormal_glucose_homeostasis | 0.51477451 |
| 156 | MP0000955_abnormal_spinal_cord | 0.51436245 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Sudden death (HP:0001699) | 7.51080241 |
| 2 | Premature rupture of membranes (HP:0001788) | 6.11463376 |
| 3 | Atrial fibrillation (HP:0005110) | 5.89079968 |
| 4 | Ventricular tachycardia (HP:0004756) | 5.88606251 |
| 5 | Protrusio acetabuli (HP:0003179) | 5.64635154 |
| 6 | Primary atrial arrhythmia (HP:0001692) | 5.59544761 |
| 7 | Aortic aneurysm (HP:0004942) | 5.56591395 |
| 8 | Supraventricular tachycardia (HP:0004755) | 5.38557104 |
| 9 | Syncope (HP:0001279) | 5.27666303 |
| 10 | Supraventricular arrhythmia (HP:0005115) | 5.26246218 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 5.15167312 |
| 12 | Calf muscle hypertrophy (HP:0008981) | 5.15072708 |
| 13 | Vascular tortuosity (HP:0004948) | 4.99289944 |
| 14 | Aortic dissection (HP:0002647) | 4.95631833 |
| 15 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.74471634 |
| 16 | Bundle branch block (HP:0011710) | 4.51860340 |
| 17 | Exercise-induced myalgia (HP:0003738) | 4.51492213 |
| 18 | Prolonged QT interval (HP:0001657) | 4.42421967 |
| 19 | Exercise-induced muscle cramps (HP:0003710) | 4.42214834 |
| 20 | Abnormality of the calf musculature (HP:0001430) | 4.38481481 |
| 21 | Lipoatrophy (HP:0100578) | 4.38354455 |
| 22 | Right ventricular cardiomyopathy (HP:0011663) | 4.35394107 |
| 23 | Palpitations (HP:0001962) | 4.34198559 |
| 24 | Arterial tortuosity (HP:0005116) | 4.30886390 |
| 25 | Muscle fiber splitting (HP:0003555) | 4.23940170 |
| 26 | Ankle contracture (HP:0006466) | 4.21159442 |
| 27 | Ventricular fibrillation (HP:0001663) | 4.06619354 |
| 28 | Hyporeflexia of lower limbs (HP:0002600) | 4.03425192 |
| 29 | Myoglobinuria (HP:0002913) | 4.00872554 |
| 30 | Follicular hyperkeratosis (HP:0007502) | 3.92740694 |
| 31 | Ventricular arrhythmia (HP:0004308) | 3.80419246 |
| 32 | Soft skin (HP:0000977) | 3.80073322 |
| 33 | Heart block (HP:0012722) | 3.60329703 |
| 34 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.59119497 |
| 35 | Acute necrotizing encephalopathy (HP:0006965) | 3.58190134 |
| 36 | Myotonia (HP:0002486) | 3.57537466 |
| 37 | Dilated cardiomyopathy (HP:0001644) | 3.57039008 |
| 38 | Bladder diverticulum (HP:0000015) | 3.51437731 |
| 39 | Abnormality of dentin (HP:0010299) | 3.47952666 |
| 40 | Pheochromocytoma (HP:0002666) | 3.42584925 |
| 41 | Atrioventricular block (HP:0001678) | 3.40751376 |
| 42 | Abnormal EKG (HP:0003115) | 3.37928889 |
| 43 | Abnormal atrioventricular conduction (HP:0005150) | 3.36529382 |
| 44 | Spinal rigidity (HP:0003306) | 3.29350274 |
| 45 | Subaortic stenosis (HP:0001682) | 3.27974781 |
| 46 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.27974781 |
| 47 | Wormian bones (HP:0002645) | 3.24777636 |
| 48 | Hypoplastic left heart (HP:0004383) | 3.23593105 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 3.23557875 |
| 50 | Neonatal short-limb short stature (HP:0008921) | 3.21219406 |
| 51 | EMG: myopathic abnormalities (HP:0003458) | 3.20743977 |
| 52 | Progressive macrocephaly (HP:0004481) | 3.16083399 |
| 53 | Neuroendocrine neoplasm (HP:0100634) | 3.11245212 |
| 54 | Hypoventilation (HP:0002791) | 3.09988183 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 3.03574819 |
| 56 | Hepatic necrosis (HP:0002605) | 3.01212673 |
| 57 | Dilatation of the ascending aorta (HP:0005111) | 3.00117600 |
| 58 | Slender build (HP:0001533) | 2.99721646 |
| 59 | Left ventricular hypertrophy (HP:0001712) | 2.98681005 |
| 60 | Aneurysm (HP:0002617) | 2.98042007 |
| 61 | Myokymia (HP:0002411) | 2.97802162 |
| 62 | Acute encephalopathy (HP:0006846) | 2.95819657 |
| 63 | Peritonitis (HP:0002586) | 2.94050106 |
| 64 | Mitochondrial inheritance (HP:0001427) | 2.92166477 |
| 65 | Atrophic scars (HP:0001075) | 2.91501677 |
| 66 | Spondylolisthesis (HP:0003302) | 2.90985370 |
| 67 | Hepatocellular necrosis (HP:0001404) | 2.87378741 |
| 68 | Rhabdomyolysis (HP:0003201) | 2.75202718 |
| 69 | Increased connective tissue (HP:0009025) | 2.75169995 |
| 70 | Mitral valve prolapse (HP:0001634) | 2.74698396 |
| 71 | Focal motor seizures (HP:0011153) | 2.74511392 |
| 72 | Long toe (HP:0010511) | 2.73503981 |
| 73 | Fragile skin (HP:0001030) | 2.70993192 |
| 74 | Difficulty running (HP:0009046) | 2.70230048 |
| 75 | Wide anterior fontanel (HP:0000260) | 2.69796549 |
| 76 | Cervical subluxation (HP:0003308) | 2.69612582 |
| 77 | Increased CSF lactate (HP:0002490) | 2.67209585 |
| 78 | Elbow flexion contracture (HP:0002987) | 2.63941633 |
| 79 | Bowel diverticulosis (HP:0005222) | 2.58819621 |
| 80 | Ketoacidosis (HP:0001993) | 2.58629255 |
| 81 | Hypothermia (HP:0002045) | 2.57375100 |
| 82 | Abnormality of the pulmonary veins (HP:0011718) | 2.57050902 |
| 83 | Cerebral edema (HP:0002181) | 2.56316700 |
| 84 | Abnormal umbilical cord blood vessels (HP:0011403) | 2.49997333 |
| 85 | Single umbilical artery (HP:0001195) | 2.49997333 |
| 86 | Abnormality of the fetal cardiovascular system (HP:0010948) | 2.49997333 |
| 87 | Coronal craniosynostosis (HP:0004440) | 2.45037204 |
| 88 | Hip contracture (HP:0003273) | 2.44104163 |
| 89 | Hypoplastic heart (HP:0001961) | 2.43946960 |
| 90 | Conjunctival hamartoma (HP:0100780) | 2.39884358 |
| 91 | Dysmetric saccades (HP:0000641) | 2.38268734 |
| 92 | Complete atrioventricular canal defect (HP:0001674) | 2.33767156 |
| 93 | Muscle stiffness (HP:0003552) | 2.30362944 |
| 94 | Blue sclerae (HP:0000592) | 2.30306605 |
| 95 | Mitral regurgitation (HP:0001653) | 2.29870194 |
| 96 | Hydroureter (HP:0000072) | 2.28476176 |
| 97 | Joint laxity (HP:0001388) | 2.28207626 |
| 98 | Increased muscle lipid content (HP:0009058) | 2.27537385 |
| 99 | Respiratory failure (HP:0002878) | 2.26381533 |
| 100 | Shallow orbits (HP:0000586) | 2.26213618 |
| 101 | Lactic acidosis (HP:0003128) | 2.26034637 |
| 102 | Overgrowth (HP:0001548) | 2.24610697 |
| 103 | Central scotoma (HP:0000603) | 2.24566355 |
| 104 | Aortic regurgitation (HP:0001659) | 2.23628540 |
| 105 | Partial duplication of the phalanx of hand (HP:0009999) | 2.22876373 |
| 106 | Difficulty climbing stairs (HP:0003551) | 2.18484333 |
| 107 | Knee flexion contracture (HP:0006380) | 2.18068793 |
| 108 | Foot dorsiflexor weakness (HP:0009027) | 2.17284310 |
| 109 | Hyperextensible skin (HP:0000974) | 2.16730628 |
| 110 | Palmoplantar keratoderma (HP:0000982) | 2.15751203 |
| 111 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15371233 |
| 112 | Increased serum pyruvate (HP:0003542) | 2.14609635 |
| 113 | Abnormality of glycolysis (HP:0004366) | 2.14609635 |
| 114 | Abnormality of pyruvate family amino acid metabolism (HP:0010915) | 2.14340612 |
| 115 | Abnormality of alanine metabolism (HP:0010916) | 2.14340612 |
| 116 | Hyperalaninemia (HP:0003348) | 2.14340612 |
| 117 | Increased intramyocellular lipid droplets (HP:0012240) | 2.14141968 |
| 118 | Limited hip movement (HP:0008800) | 2.12373472 |
| 119 | Genu recurvatum (HP:0002816) | 2.11361405 |
| 120 | Abnormality of the foot musculature (HP:0001436) | 2.11272893 |
| 121 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.11092070 |
| 122 | Sudden cardiac death (HP:0001645) | 2.11005099 |
| 123 | Hamartoma of the eye (HP:0010568) | 2.09653605 |
| 124 | Visual hallucinations (HP:0002367) | 2.07297261 |
| 125 | Camptodactyly of toe (HP:0001836) | 2.06327737 |
| 126 | Exercise intolerance (HP:0003546) | 2.04615637 |
| 127 | Bradycardia (HP:0001662) | 2.04592786 |
| 128 | Abnormality of the vocal cords (HP:0008777) | 2.03644001 |
| 129 | Disproportionate tall stature (HP:0001519) | 2.03459251 |
| 130 | Hypoglycemic coma (HP:0001325) | 2.01299479 |
| 131 | Limb-girdle muscle atrophy (HP:0003797) | 2.01128295 |
| 132 | Focal seizures (HP:0007359) | 2.00861642 |
| 133 | Partial duplication of thumb phalanx (HP:0009944) | 1.99658492 |
| 134 | Ragged-red muscle fibers (HP:0003200) | 1.99141925 |
| 135 | Pulmonary artery stenosis (HP:0004415) | 1.99075745 |
| 136 | Neoplasm of the adrenal gland (HP:0100631) | 1.96789186 |
| 137 | Biconcave vertebral bodies (HP:0004586) | 1.95974385 |
| 138 | Atrioventricular canal defect (HP:0006695) | 1.95279398 |
| 139 | Distal lower limb muscle weakness (HP:0009053) | 1.93579055 |
| 140 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.92839108 |
| 141 | Cerebral hemorrhage (HP:0001342) | 1.92556954 |
| 142 | Athetosis (HP:0002305) | 1.89845706 |
| 143 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.88729110 |
| 144 | Rapidly progressive (HP:0003678) | 1.88270006 |
| 145 | Areflexia of lower limbs (HP:0002522) | 1.88260413 |
| 146 | Dicarboxylic aciduria (HP:0003215) | 1.87178552 |
| 147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.87178552 |
| 148 | Patent foramen ovale (HP:0001655) | 1.86525158 |
| 149 | Limb-girdle muscle weakness (HP:0003325) | 1.86261246 |
| 150 | Ectopia lentis (HP:0001083) | 1.85139101 |
| 151 | Abnormality of the umbilical cord (HP:0010881) | 1.83741613 |
| 152 | Optic disc pallor (HP:0000543) | 1.82937141 |
| 153 | Generalized amyotrophy (HP:0003700) | 1.82415458 |
| 154 | Cerebral aneurysm (HP:0004944) | 1.81417812 |
| 155 | Lipid accumulation in hepatocytes (HP:0006561) | 1.81087913 |
| 156 | Muscle fiber inclusion bodies (HP:0100299) | 1.80381749 |
| 157 | Mesomelia (HP:0003027) | 1.80027253 |
| 158 | Lower limb amyotrophy (HP:0007210) | 1.79997752 |
| 159 | Distal upper limb amyotrophy (HP:0007149) | 1.79860337 |
| 160 | Upper limb amyotrophy (HP:0009129) | 1.79860337 |
| 161 | Distal lower limb amyotrophy (HP:0008944) | 1.79619510 |
| 162 | Anxiety (HP:0000739) | 1.77585207 |
| 163 | Broad metatarsal (HP:0001783) | 1.76696918 |
| 164 | Tinnitus (HP:0000360) | 1.75963052 |
| 165 | Congestive heart failure (HP:0001635) | 1.74820045 |
| 166 | Atonic seizures (HP:0010819) | 1.73120579 |
| 167 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.73094342 |
| 168 | Impaired pain sensation (HP:0007328) | 1.73075340 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | LMTK2 | 4.32440268 |
| 2 | TTN | 3.89862944 |
| 3 | PHKG2 | 3.76949644 |
| 4 | PHKG1 | 3.76949644 |
| 5 | MYLK | 3.44755560 |
| 6 | PDK4 | 3.44672497 |
| 7 | PDK3 | 3.44672497 |
| 8 | DDR2 | 2.83331374 |
| 9 | PIK3CG | 2.74016096 |
| 10 | FLT3 | 2.58952647 |
| 11 | MAP3K4 | 2.44181955 |
| 12 | NEK9 | 2.34484892 |
| 13 | OBSCN | 2.33868781 |
| 14 | PAK2 | 2.19953916 |
| 15 | DMPK | 2.19925789 |
| 16 | NEK1 | 2.05572424 |
| 17 | PDK2 | 2.05081069 |
| 18 | PKN2 | 1.99309373 |
| 19 | NTRK3 | 1.98636629 |
| 20 | AKT3 | 1.92754857 |
| 21 | PINK1 | 1.82352268 |
| 22 | TIE1 | 1.76484583 |
| 23 | NTRK1 | 1.74439839 |
| 24 | PTK2 | 1.69056175 |
| 25 | STK24 | 1.67345747 |
| 26 | MUSK | 1.64445890 |
| 27 | PAK3 | 1.63479188 |
| 28 | MAP2K4 | 1.59602430 |
| 29 | CAMK2D | 1.58002575 |
| 30 | MAP2K7 | 1.57556728 |
| 31 | PIK3CA | 1.56658560 |
| 32 | MAP3K12 | 1.56387306 |
| 33 | EPHB2 | 1.56107167 |
| 34 | LATS1 | 1.51305306 |
| 35 | TESK1 | 1.48819740 |
| 36 | TGFBR2 | 1.38119256 |
| 37 | WNK1 | 1.36173318 |
| 38 | MINK1 | 1.32795567 |
| 39 | WNK4 | 1.28298276 |
| 40 | MARK1 | 1.28179033 |
| 41 | ADRBK2 | 1.27931721 |
| 42 | PRKD2 | 1.23360371 |
| 43 | MAP3K9 | 1.21521699 |
| 44 | GRK5 | 1.20325799 |
| 45 | SIK1 | 1.18987344 |
| 46 | BCKDK | 1.17173711 |
| 47 | CAMK2A | 1.15982125 |
| 48 | TRIB3 | 1.13300329 |
| 49 | PRKD1 | 1.04769389 |
| 50 | CAMK4 | 1.04326532 |
| 51 | STK38L | 1.01893613 |
| 52 | STK39 | 1.01565676 |
| 53 | CASK | 0.99347733 |
| 54 | PAK6 | 0.95260957 |
| 55 | INSRR | 0.94722953 |
| 56 | PRKCE | 0.94358699 |
| 57 | CAMK1 | 0.92914608 |
| 58 | STK38 | 0.91640677 |
| 59 | DYRK1B | 0.91023085 |
| 60 | UHMK1 | 0.90318251 |
| 61 | ROCK1 | 0.89859019 |
| 62 | EPHA4 | 0.89763094 |
| 63 | KSR2 | 0.89440655 |
| 64 | LATS2 | 0.89137777 |
| 65 | CDC42BPA | 0.89044754 |
| 66 | ERBB4 | 0.88752215 |
| 67 | DAPK2 | 0.82817555 |
| 68 | PDGFRB | 0.82166773 |
| 69 | ILK | 0.80941698 |
| 70 | DAPK3 | 0.78437189 |
| 71 | GRK1 | 0.77339504 |
| 72 | RET | 0.75543005 |
| 73 | CAMK2G | 0.75343418 |
| 74 | ROCK2 | 0.75317666 |
| 75 | * ADRBK1 | 0.73563732 |
| 76 | MAP3K6 | 0.73488012 |
| 77 | MAP3K7 | 0.72631439 |
| 78 | KIT | 0.71494934 |
| 79 | PRKG2 | 0.68055966 |
| 80 | MAPK12 | 0.67170961 |
| 81 | PRKAA1 | 0.66155989 |
| 82 | PRKCH | 0.65266154 |
| 83 | NTRK2 | 0.65087552 |
| 84 | SGK223 | 0.62049092 |
| 85 | SGK494 | 0.62049092 |
| 86 | CDK5 | 0.61446443 |
| 87 | MET | 0.61127401 |
| 88 | CAMKK1 | 0.60148729 |
| 89 | MAP2K1 | 0.58621560 |
| 90 | MAP3K5 | 0.58287467 |
| 91 | PDGFRA | 0.58042947 |
| 92 | PTK2B | 0.58015754 |
| 93 | PKN1 | 0.56914727 |
| 94 | PRKACA | 0.56660649 |
| 95 | PDPK1 | 0.56431555 |
| 96 | PRKACB | 0.55855261 |
| 97 | LIMK1 | 0.53451035 |
| 98 | CAMK2B | 0.53107580 |
| 99 | SGK2 | 0.52818461 |
| 100 | FER | 0.52579819 |
| 101 | PRKACG | 0.52569726 |
| 102 | MAPK13 | 0.52564165 |
| 103 | SGK3 | 0.52544393 |
| 104 | PLK2 | 0.51811612 |
| 105 | RPS6KL1 | 0.51257774 |
| 106 | RPS6KC1 | 0.51257774 |
| 107 | PRKD3 | 0.50928098 |
| 108 | MAPK4 | 0.50019075 |
| 109 | JAK1 | 0.49832577 |
| 110 | PDK1 | 0.49720079 |
| 111 | PIM2 | 0.47970278 |
| 112 | ABL2 | 0.47448777 |
| 113 | GSK3A | 0.46283205 |
| 114 | RIPK1 | 0.46045269 |
| 115 | MELK | 0.45337121 |
| 116 | PRKAA2 | 0.44037506 |
| 117 | RPS6KA2 | 0.43259189 |
| 118 | PRKCG | 0.42684089 |
| 119 | MTOR | 0.42164914 |
| 120 | MAP3K1 | 0.40921024 |
| 121 | STK11 | 0.39975615 |
| 122 | MAPK7 | 0.39611566 |
| 123 | PAK4 | 0.39367378 |
| 124 | SGK1 | 0.39290591 |
| 125 | CAMKK2 | 0.39272832 |
| 126 | TRPM7 | 0.38847530 |
| 127 | MAPKAPK3 | 0.38676852 |
| 128 | EPHB1 | 0.38375272 |
| 129 | RPS6KA6 | 0.37432920 |
| 130 | PNCK | 0.37366137 |
| 131 | ICK | 0.35769276 |
| 132 | FGFR1 | 0.34599511 |
| 133 | RPS6KA3 | 0.31705342 |
| 134 | STK4 | 0.31372678 |
| 135 | PRKG1 | 0.29574142 |
| 136 | CDK8 | 0.28126267 |
| 137 | ARAF | 0.27598465 |
| 138 | PAK1 | 0.26676042 |
| 139 | ERN1 | 0.25080902 |
| 140 | DAPK1 | 0.24510762 |
| 141 | STK3 | 0.22329775 |
| 142 | SRC | 0.21497675 |
| 143 | MOS | 0.21339763 |
| 144 | TGFBR1 | 0.20245006 |
| 145 | MAPKAPK2 | 0.20188872 |
| 146 | PRKCD | 0.19507497 |
| 147 | GRK6 | 0.19253449 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 4.74082986 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.49795357 |
| 3 | ECM-receptor interaction_Homo sapiens_hsa04512 | 3.34401623 |
| 4 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 3.26572931 |
| 5 | Parkinsons disease_Homo sapiens_hsa05012 | 3.14062611 |
| 6 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 3.00702440 |
| 7 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.77740917 |
| 8 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.61119545 |
| 9 | Alzheimers disease_Homo sapiens_hsa05010 | 2.45263666 |
| 10 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.43746748 |
| 11 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.30126426 |
| 12 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.99104482 |
| 13 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.97539044 |
| 14 | Huntingtons disease_Homo sapiens_hsa05016 | 1.94547815 |
| 15 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.92152940 |
| 16 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.83664778 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.83466277 |
| 18 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.82327565 |
| 19 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.81134132 |
| 20 | * Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 1.69358130 |
| 21 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.68680717 |
| 22 | Carbon metabolism_Homo sapiens_hsa01200 | 1.62749859 |
| 23 | Amoebiasis_Homo sapiens_hsa05146 | 1.59955300 |
| 24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.56223252 |
| 25 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.52796085 |
| 26 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.51463706 |
| 27 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.48233936 |
| 28 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.46613312 |
| 29 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.45133845 |
| 30 | Adherens junction_Homo sapiens_hsa04520 | 1.44819567 |
| 31 | Circadian entrainment_Homo sapiens_hsa04713 | 1.43708161 |
| 32 | Olfactory transduction_Homo sapiens_hsa04740 | 1.40961591 |
| 33 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.40757313 |
| 34 | Melanoma_Homo sapiens_hsa05218 | 1.38711436 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.36342000 |
| 36 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 1.36337732 |
| 37 | Renin secretion_Homo sapiens_hsa04924 | 1.33704183 |
| 38 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.30428344 |
| 39 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.28619658 |
| 40 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.28026595 |
| 41 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.27407577 |
| 42 | Basal cell carcinoma_Homo sapiens_hsa05217 | 1.27399845 |
| 43 | Insulin secretion_Homo sapiens_hsa04911 | 1.25689972 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.22839451 |
| 45 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.22050365 |
| 46 | * Calcium signaling pathway_Homo sapiens_hsa04020 | 1.19371807 |
| 47 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.17435321 |
| 48 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13378387 |
| 49 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.13258591 |
| 50 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.12773485 |
| 51 | * Cholinergic synapse_Homo sapiens_hsa04725 | 1.11951335 |
| 52 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.11131553 |
| 53 | GABAergic synapse_Homo sapiens_hsa04727 | 1.09992121 |
| 54 | * PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 1.09033335 |
| 55 | Taste transduction_Homo sapiens_hsa04742 | 1.08807126 |
| 56 | Long-term potentiation_Homo sapiens_hsa04720 | 1.08565569 |
| 57 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.07334797 |
| 58 | Morphine addiction_Homo sapiens_hsa05032 | 1.06497262 |
| 59 | Nicotine addiction_Homo sapiens_hsa05033 | 1.05746245 |
| 60 | Salivary secretion_Homo sapiens_hsa04970 | 1.04207971 |
| 61 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.99851955 |
| 62 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.98966228 |
| 63 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.97885251 |
| 64 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.96234362 |
| 65 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.96113190 |
| 66 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.95375137 |
| 67 | Pathways in cancer_Homo sapiens_hsa05200 | 0.94030998 |
| 68 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92990089 |
| 69 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.91256219 |
| 70 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91177828 |
| 71 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.87796873 |
| 72 | Gap junction_Homo sapiens_hsa04540 | 0.87380173 |
| 73 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.86484536 |
| 74 | Cocaine addiction_Homo sapiens_hsa05030 | 0.84583143 |
| 75 | Platelet activation_Homo sapiens_hsa04611 | 0.82702661 |
| 76 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.81153651 |
| 77 | * cAMP signaling pathway_Homo sapiens_hsa04024 | 0.80013751 |
| 78 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78344658 |
| 79 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.77429568 |
| 80 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.77280180 |
| 81 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.76507953 |
| 82 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.75074586 |
| 83 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.74817951 |
| 84 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.74545612 |
| 85 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.74499111 |
| 86 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71232247 |
| 87 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70334784 |
| 88 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.70141771 |
| 89 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.69213617 |
| 90 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.68966494 |
| 91 | Bladder cancer_Homo sapiens_hsa05219 | 0.68837446 |
| 92 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.63947945 |
| 93 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63083631 |
| 94 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.62349253 |
| 95 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.62271312 |
| 96 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.61633843 |
| 97 | Insulin resistance_Homo sapiens_hsa04931 | 0.60927827 |
| 98 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.59808840 |
| 99 | Prion diseases_Homo sapiens_hsa05020 | 0.59803232 |
| 100 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.58395123 |
| 101 | Glioma_Homo sapiens_hsa05214 | 0.58250572 |
| 102 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.54852036 |
| 103 | Long-term depression_Homo sapiens_hsa04730 | 0.54465955 |
| 104 | Endometrial cancer_Homo sapiens_hsa05213 | 0.54385749 |
| 105 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.54274603 |
| 106 | Prostate cancer_Homo sapiens_hsa05215 | 0.51850363 |
| 107 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.51708316 |
| 108 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.51638396 |
| 109 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.49481139 |
| 110 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.48611774 |
| 111 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.47702691 |
| 112 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.47321887 |
| 113 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.45455810 |
| 114 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.44963780 |
| 115 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.43931648 |
| 116 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.43750294 |
| 117 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.42897071 |
| 118 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.41479549 |
| 119 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40952760 |
| 120 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.40624033 |
| 121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.40260487 |
| 122 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39496318 |
| 123 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.38866387 |
| 124 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.38750231 |
| 125 | Endocytosis_Homo sapiens_hsa04144 | 0.38174120 |
| 126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.38149072 |
| 127 | Malaria_Homo sapiens_hsa05144 | 0.38114061 |
| 128 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.37702898 |
| 129 | Bile secretion_Homo sapiens_hsa04976 | 0.37570724 |
| 130 | Focal adhesion_Homo sapiens_hsa04510 | 0.36809692 |
| 131 | Melanogenesis_Homo sapiens_hsa04916 | 0.36542560 |
| 132 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.36468278 |
| 133 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33545242 |
| 134 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.31608287 |
| 135 | Axon guidance_Homo sapiens_hsa04360 | 0.31445232 |
| 136 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.31322463 |
| 137 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.29718675 |
| 138 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.29294464 |
| 139 | * Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.27334345 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.26817206 |
| 141 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.25859853 |
| 142 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.25308952 |
| 143 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.23644343 |
| 144 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.21813325 |
| 145 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.21587900 |

